Synthetic TILs: Engineered Tumor-Infiltrating Lymphocytes With Improved Therapeutic Potential

by Anaïs Jiménez-Reinoso, Anaïs Jiménez-Reinoso, Daniel Nehme-Álvarez, Daniel Nehme-Álvarez, Carmen Domínguez-Alonso, Carmen Domínguez-Alonso, Luis Álvarez-Vallina, Luis Álvarez-Vallina
Published 2021-02-01

Intra-Tumour Heterogeneity Is One of the Main Sources of Inter-Observer Variation in Scoring Stromal Tumour Infiltrating Lymphocytes in Triple Negative Breast Cancer

by Darren Kilmartin, Mark O’Loughlin, Xavier Andreu, Zsuzsanna Bagó-Horváth, Simonetta Bianchi, Ewa Chmielik, Gábor Cserni, Paulo Figueiredo, Giuseppe Floris, Maria Pia Foschini, Anikó Kovács, Päivi Heikkilä, Janina Kulka, Anne-Vibeke Laenkholm, Inta Liepniece-Karele, Caterina Marchiò, Elena Provenzano, Peter Regitnig, Angelika Reiner, Aleš Ryška, Anna Sapino, Elisabeth Specht Stovgaard, Cecily Quinn, Vasiliki Zolota, Mark Webber, Davood Roshan, Sharon A. Glynn, Grace Callagy
Published 2021-08-01

The identification of tumor-infiltrating lymphocytes in patients with stomach cancer

by Gulnoz G. Khakimova, Yana A. Bozhchenko, Tatyana N. Zabotina, Alexey A. Tryakin
Published 2021-08-01

Impact of <i>BRCA</i> Mutation Status on Tumor Infiltrating Lymphocytes (TILs), Response to Treatment, and Prognosis in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy

by Beatriz Grandal, Clémence Evrevin, Enora Laas, Isabelle Jardin, Sonia Rozette, Lucie Laot, Elise Dumas, Florence Coussy, Jean-Yves Pierga, Etienne Brain, Claire Saule, Dominique Stoppa-Lyonnet, Sophie Frank, Claire Sénéchal, Marick Lae, Diane De Croze, Guillaume Bataillon, Julien Guerin, Fabien Reyal, Anne-Sophie Hamy
Published 2020-12-01

Functional Heterogeneity of CD4+ Tumor-Infiltrating Lymphocytes With a Resident Memory Phenotype in NSCLC

by Anna E. Oja, Berber Piet, David van der Zwan, Hans Blaauwgeers, Mark Mensink, Sander de Kivit, Jannie Borst, Martijn A. Nolte, René A. W. van Lier, Regina Stark, Pleun Hombrink
Published 2018-11-01

Emerging Opportunities of Radiotherapy Combined With Immunotherapy in the Era of Breast Cancer Heterogeneity

by Pelagia G. Tsoutsou, Pelagia G. Tsoutsou, Pelagia G. Tsoutsou, Khalil Zaman, Silvia Martin Lluesma, Laurene Cagnon, Lana Kandalaft, Marie-Catherine Vozenin
Published 2018-12-01

Should Tumor Infiltrating Lymphocytes, Androgen Receptor, and FOXA1 Expression Predict the Clinical Outcome in Triple Negative Breast Cancer Patients?

by Anita Mangia, Concetta Saponaro, Alessandro Vagheggini, Giuseppina Opinto, Matteo Centonze, Chiara Vicenti, Ondina Popescu, Maria Pastena, Francesco Giotta, Nicola Silvestris
Published 2019-09-01

Comedications influence immune infiltration and pathological response to neoadjuvant chemotherapy in breast cancer

by Anne-Sophie Hamy, Lisa Derosa, Constance Valdelièvre, Satoru Yonekura, Paule Opolon, Maël Priour, Julien Guerin, Jean-Yves Pierga, Bernard Asselain, Diane De Croze, Alice Pinheiro, Marick Lae, Laure-Sophie Talagrand, Enora Laas, Lauren Darrigues, Beatriz Grandal, Elisabetta Marangoni, Elodie Montaudon, Guido Kroemer, Laurence Zitvogel, Fabien Reyal
Published 2020-01-01

TIM-3 and CEACAM1 are Prognostic Factors in Head and Neck Squamous Cell Carcinoma

by Fan Yang, Fan Yang, Fan Yang, Fan Yang, Fan Yang, Fan Yang, Ziqing Zeng, Ziqing Zeng, Ziqing Zeng, Ziqing Zeng, Ziqing Zeng, Jing Li, Jing Li, Jing Li, Jing Li, Jing Li, Xiubao Ren, Xiubao Ren, Xiubao Ren, Xiubao Ren, Xiubao Ren, Xiubao Ren, Feng Wei, Feng Wei, Feng Wei, Feng Wei, Feng Wei
Published 2021-07-01

Expression and Prognostic Value of Tumor-Infiltrating Lymphocytes and PD-L1 in Hepatocellular Carcinoma

by Nie H, He T, Wang L, Zhang L
Published 2021-02-01

Cellular Virotherapy Increases Tumor-Infiltrating Lymphocytes (TIL) and Decreases their PD-1⁺ Subsets in Mouse Immunocompetent Models

by Alvaro Morales-Molina, Miguel Ángel Rodríguez-Milla, Alicia Gimenez-Sanchez, Ana Judith Perisé-Barrios, Javier García-Castro
Published 2020-07-01

Thoughts about the work of translation and interpretation in sign language as ethical and political practice in self care

by Lucyenne Matos da Costa Vieira-Machado, Jeferson Bruno Moreira Santana
Published 2015-10-01

Prognostic Role of Tumor-Infiltrating Lymphocytes in Esophagus Cancer: a Meta-Analysis

by Xiao Zheng, Xing Song, Yingjie Shao, Bin Xu, Wenwei Hu, Qi Zhou, Lujun Chen, Dachuan Zhang, Changping Wu, Jingting Jiang
Published 2018-01-01

Tumour-infiltrating lymphocytes as a prognostic and tamoxifen predictive marker in premenopausal breast cancer: data from a randomised trial with long-term follow-up

by Christine Lundgren, Pär-Ola Bendahl, Maria Ekholm, Mårten Fernö, Carina Forsare, Ute Krüger, Bo Nordenskjöld, Olle Stål, Lisa Rydén
Published 2020-12-01

Tumour-infiltrating lymphocytes and response to neoadjuvant letrozole in patients with early oestrogen receptor-positive breast cancer: analysis from a nationwide phase II DBCG tri...

by Signe Korsgaard Skriver, Maj-Britt Jensen, Ann Soegaard Knoop, Bent Ejlertsen, Anne-Vibeke Laenkholm
Published 2020-05-01

Programmed death ligand-1 and CD8 tumor-infiltrating lymphocytes (TILs) as prognostic predictors in ovarian high-grade serous carcinoma (HGSC)

by Mayada Saad Farrag, Khaled Abdelwahab, Nesrine Saad Farrag, Waleed Elsayed Elrefaie, Ziad Emarah
Published 2021-07-01

Functional heterogeneity of lymphocytic patterns in primary melanoma dissected through single-cell multiplexing

by Francesca Maria Bosisio, Asier Antoranz, Yannick van Herck, Maddalena Maria Bolognesi, Lukas Marcelis, Clizia Chinello, Jasper Wouters, Fulvio Magni, Leonidas Alexopoulos, Marguerite Stas, Veerle Boecxstaens, Oliver Bechter, Giorgio Cattoretti, Joost van den Oord
Published 2020-02-01

TILs Immunophenotype in Breast Cancer Predicts Local Failure and Overall Survival: Analysis in a Large Radiotherapy Trial with Long-Term Follow-Up

by Ewan Millar, Lois Browne, Iveta Slapetova, Fei Shang, Yuqi Ren, Rachel Bradshaw, Heather Ann Brauer, Sandra O’Toole, Julia Beretov, Renee Whan, Peter H. Graham
Published 2020-08-01

Distinctive features of tumor-infiltrating γδ T lymphocytes in human colorectal cancer

by S. Meraviglia, E. Lo Presti, M. Tosolini, C. La Mendola, V. Orlando, M. Todaro, V. Catalano, G. Stassi, G. Cicero, S. Vieni, J. J. Fourniè, F. Dieli
Published 2017-10-01

Prognostic value of PD-L1 expression on tumor cells combined with CD8+ TIL density in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradioth...

by Kathrin Gennen, Lukas Käsmann, Julian Taugner, Chukwuka Eze, Monika Karin, Olarn Roengvoraphoj, Jens Neumann, Amanda Tufman, Michael Orth, Simone Reu, Claus Belka, Farkhad Manapov
Published 2020-01-01